nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC15A1—Lisinopril—systemic scleroderma	0.313	0.403	CbGbCtD
Cefadroxil—SLC15A1—Captopril—systemic scleroderma	0.234	0.302	CbGbCtD
Cefadroxil—SLC22A6—Captopril—systemic scleroderma	0.129	0.166	CbGbCtD
Cefadroxil—SLC22A8—Methotrexate—systemic scleroderma	0.0584	0.0754	CbGbCtD
Cefadroxil—SLC22A6—Methotrexate—systemic scleroderma	0.0407	0.0526	CbGbCtD
Cefadroxil—Agranulocytosis—Leflunomide—systemic scleroderma	0.000816	0.00362	CcSEcCtD
Cefadroxil—Tension—Captopril—systemic scleroderma	0.000814	0.00361	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000814	0.00361	CcSEcCtD
Cefadroxil—Nervousness—Captopril—systemic scleroderma	0.000805	0.00357	CcSEcCtD
Cefadroxil—Arthralgia—Mometasone—systemic scleroderma	0.000804	0.00357	CcSEcCtD
Cefadroxil—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00355	CcSEcCtD
Cefadroxil—Pancytopenia—Lisinopril—systemic scleroderma	0.0008	0.00355	CcSEcCtD
Cefadroxil—Somnolence—Pentoxifylline—systemic scleroderma	0.000794	0.00352	CcSEcCtD
Cefadroxil—Haemoglobin—Leflunomide—systemic scleroderma	0.000789	0.0035	CcSEcCtD
Cefadroxil—Neutropenia—Lisinopril—systemic scleroderma	0.000788	0.0035	CcSEcCtD
Cefadroxil—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000786	0.00349	CcSEcCtD
Cefadroxil—Erythema multiforme—Azathioprine—systemic scleroderma	0.000786	0.00349	CcSEcCtD
Cefadroxil—Haemorrhage—Leflunomide—systemic scleroderma	0.000785	0.00348	CcSEcCtD
Cefadroxil—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000779	0.00346	CcSEcCtD
Cefadroxil—Anaphylactic shock—Mometasone—systemic scleroderma	0.000771	0.00342	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000769	0.00341	CcSEcCtD
Cefadroxil—Angioedema—Captopril—systemic scleroderma	0.000758	0.00336	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000754	0.00334	CcSEcCtD
Cefadroxil—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000753	0.00334	CcSEcCtD
Cefadroxil—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000749	0.00332	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000745	0.00331	CcSEcCtD
Cefadroxil—Erythema multiforme—Leflunomide—systemic scleroderma	0.000742	0.00329	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00073	0.00324	CcSEcCtD
Cefadroxil—Urticaria—Pentoxifylline—systemic scleroderma	0.000709	0.00315	CcSEcCtD
Cefadroxil—Arthralgia—Captopril—systemic scleroderma	0.000706	0.00313	CcSEcCtD
Cefadroxil—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000706	0.00313	CcSEcCtD
Cefadroxil—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000706	0.00313	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000702	0.00312	CcSEcCtD
Cefadroxil—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00311	CcSEcCtD
Cefadroxil—Agranulocytosis—Lisinopril—systemic scleroderma	0.000701	0.00311	CcSEcCtD
Cefadroxil—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00306	CcSEcCtD
Cefadroxil—Dyspepsia—Mometasone—systemic scleroderma	0.000678	0.00301	CcSEcCtD
Cefadroxil—Anaphylactic shock—Captopril—systemic scleroderma	0.000677	0.003	CcSEcCtD
Cefadroxil—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000667	0.00296	CcSEcCtD
Cefadroxil—Thrombocytopenia—Captopril—systemic scleroderma	0.000663	0.00294	CcSEcCtD
Cefadroxil—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000658	0.00292	CcSEcCtD
Cefadroxil—Muscle spasms—Leflunomide—systemic scleroderma	0.000657	0.00292	CcSEcCtD
Cefadroxil—Asthenia—Pentoxifylline—systemic scleroderma	0.000641	0.00284	CcSEcCtD
Cefadroxil—Tension—Mycophenolic acid—systemic scleroderma	0.00064	0.00284	CcSEcCtD
Cefadroxil—Erythema multiforme—Lisinopril—systemic scleroderma	0.000638	0.00283	CcSEcCtD
Cefadroxil—Nervousness—Mycophenolic acid—systemic scleroderma	0.000633	0.00281	CcSEcCtD
Cefadroxil—Pruritus—Pentoxifylline—systemic scleroderma	0.000632	0.0028	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00063	0.0028	CcSEcCtD
Cefadroxil—Vaginal infection—Methotrexate—systemic scleroderma	0.00063	0.00279	CcSEcCtD
Cefadroxil—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000627	0.00278	CcSEcCtD
Cefadroxil—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000626	0.00278	CcSEcCtD
Cefadroxil—Angioedema—Leflunomide—systemic scleroderma	0.000625	0.00277	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000617	0.00274	CcSEcCtD
Cefadroxil—Arthralgia—Azathioprine—systemic scleroderma	0.000616	0.00273	CcSEcCtD
Cefadroxil—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00273	CcSEcCtD
Cefadroxil—Vertigo—Leflunomide—systemic scleroderma	0.000614	0.00273	CcSEcCtD
Cefadroxil—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000611	0.00271	CcSEcCtD
Cefadroxil—Abdominal pain—Mometasone—systemic scleroderma	0.000609	0.0027	CcSEcCtD
Cefadroxil—Body temperature increased—Mometasone—systemic scleroderma	0.000609	0.0027	CcSEcCtD
Cefadroxil—Somnolence—Captopril—systemic scleroderma	0.000602	0.00267	CcSEcCtD
Cefadroxil—Dyspepsia—Captopril—systemic scleroderma	0.000596	0.00264	CcSEcCtD
Cefadroxil—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000594	0.00264	CcSEcCtD
Cefadroxil—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000591	0.00262	CcSEcCtD
Cefadroxil—Dizziness—Pentoxifylline—systemic scleroderma	0.000591	0.00262	CcSEcCtD
Cefadroxil—Vertigo—Mycophenolic acid—systemic scleroderma	0.000586	0.0026	CcSEcCtD
Cefadroxil—Arthralgia—Leflunomide—systemic scleroderma	0.000582	0.00258	CcSEcCtD
Cefadroxil—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000578	0.00257	CcSEcCtD
Cefadroxil—Tension—Lisinopril—systemic scleroderma	0.000576	0.00256	CcSEcCtD
Cefadroxil—Nervousness—Lisinopril—systemic scleroderma	0.00057	0.00253	CcSEcCtD
Cefadroxil—Vomiting—Pentoxifylline—systemic scleroderma	0.000568	0.00252	CcSEcCtD
Cefadroxil—Convulsion—Mycophenolic acid—systemic scleroderma	0.000565	0.00251	CcSEcCtD
Cefadroxil—Muscle spasms—Lisinopril—systemic scleroderma	0.000565	0.00251	CcSEcCtD
Cefadroxil—Rash—Pentoxifylline—systemic scleroderma	0.000563	0.0025	CcSEcCtD
Cefadroxil—Dermatitis—Pentoxifylline—systemic scleroderma	0.000563	0.0025	CcSEcCtD
Cefadroxil—Headache—Pentoxifylline—systemic scleroderma	0.000559	0.00248	CcSEcCtD
Cefadroxil—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000558	0.00248	CcSEcCtD
Cefadroxil—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000555	0.00246	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Captopril—systemic scleroderma	0.000553	0.00246	CcSEcCtD
Cefadroxil—Asthenia—Mometasone—systemic scleroderma	0.000553	0.00245	CcSEcCtD
Cefadroxil—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000546	0.00242	CcSEcCtD
Cefadroxil—Pruritus—Mometasone—systemic scleroderma	0.000545	0.00242	CcSEcCtD
Cefadroxil—Hepatic failure—Methotrexate—systemic scleroderma	0.000539	0.00239	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000538	0.00239	CcSEcCtD
Cefadroxil—Angioedema—Lisinopril—systemic scleroderma	0.000537	0.00238	CcSEcCtD
Cefadroxil—Abdominal pain—Captopril—systemic scleroderma	0.000535	0.00237	CcSEcCtD
Cefadroxil—Body temperature increased—Captopril—systemic scleroderma	0.000535	0.00237	CcSEcCtD
Cefadroxil—Nausea—Pentoxifylline—systemic scleroderma	0.00053	0.00235	CcSEcCtD
Cefadroxil—Vertigo—Lisinopril—systemic scleroderma	0.000528	0.00234	CcSEcCtD
Cefadroxil—Diarrhoea—Mometasone—systemic scleroderma	0.000527	0.00234	CcSEcCtD
Cefadroxil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000521	0.00231	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000511	0.00227	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00051	0.00226	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000508	0.00226	CcSEcCtD
Cefadroxil—Tension—Mycophenolate mofetil—systemic scleroderma	0.000505	0.00224	CcSEcCtD
Cefadroxil—Arthralgia—Lisinopril—systemic scleroderma	0.0005	0.00222	CcSEcCtD
Cefadroxil—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.0005	0.00222	CcSEcCtD
Cefadroxil—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000495	0.0022	CcSEcCtD
Cefadroxil—Dyspepsia—Leflunomide—systemic scleroderma	0.000491	0.00218	CcSEcCtD
Cefadroxil—Vomiting—Mometasone—systemic scleroderma	0.00049	0.00217	CcSEcCtD
Cefadroxil—Rash—Mometasone—systemic scleroderma	0.000486	0.00216	CcSEcCtD
Cefadroxil—Asthenia—Captopril—systemic scleroderma	0.000486	0.00216	CcSEcCtD
Cefadroxil—Dermatitis—Mometasone—systemic scleroderma	0.000485	0.00215	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000485	0.00215	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000483	0.00214	CcSEcCtD
Cefadroxil—Headache—Mometasone—systemic scleroderma	0.000483	0.00214	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000482	0.00214	CcSEcCtD
Cefadroxil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000479	0.00213	CcSEcCtD
Cefadroxil—Pruritus—Captopril—systemic scleroderma	0.000479	0.00213	CcSEcCtD
Cefadroxil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000473	0.0021	CcSEcCtD
Cefadroxil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00209	CcSEcCtD
Cefadroxil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000469	0.00208	CcSEcCtD
Cefadroxil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000468	0.00208	CcSEcCtD
Cefadroxil—Neutropenia—Prednisone—systemic scleroderma	0.000468	0.00208	CcSEcCtD
Cefadroxil—Abdominal pain—Azathioprine—systemic scleroderma	0.000467	0.00207	CcSEcCtD
Cefadroxil—Body temperature increased—Azathioprine—systemic scleroderma	0.000467	0.00207	CcSEcCtD
Cefadroxil—Diarrhoea—Captopril—systemic scleroderma	0.000463	0.00206	CcSEcCtD
Cefadroxil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00205	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000459	0.00204	CcSEcCtD
Cefadroxil—Nausea—Mometasone—systemic scleroderma	0.000458	0.00203	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000456	0.00202	CcSEcCtD
Cefadroxil—Dizziness—Captopril—systemic scleroderma	0.000448	0.00199	CcSEcCtD
Cefadroxil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00198	CcSEcCtD
Cefadroxil—Urticaria—Leflunomide—systemic scleroderma	0.000443	0.00197	CcSEcCtD
Cefadroxil—Abdominal pain—Leflunomide—systemic scleroderma	0.000441	0.00196	CcSEcCtD
Cefadroxil—Body temperature increased—Leflunomide—systemic scleroderma	0.000441	0.00196	CcSEcCtD
Cefadroxil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000438	0.00194	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000437	0.00194	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000436	0.00193	CcSEcCtD
Cefadroxil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000435	0.00193	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000435	0.00193	CcSEcCtD
Cefadroxil—Vomiting—Captopril—systemic scleroderma	0.00043	0.00191	CcSEcCtD
Cefadroxil—Rash—Captopril—systemic scleroderma	0.000427	0.00189	CcSEcCtD
Cefadroxil—Dermatitis—Captopril—systemic scleroderma	0.000426	0.00189	CcSEcCtD
Cefadroxil—Somnolence—Lisinopril—systemic scleroderma	0.000426	0.00189	CcSEcCtD
Cefadroxil—Headache—Captopril—systemic scleroderma	0.000424	0.00188	CcSEcCtD
Cefadroxil—Dyspepsia—Lisinopril—systemic scleroderma	0.000422	0.00187	CcSEcCtD
Cefadroxil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000421	0.00187	CcSEcCtD
Cefadroxil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000421	0.00187	CcSEcCtD
Cefadroxil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00186	CcSEcCtD
Cefadroxil—Eosinophilia—Methotrexate—systemic scleroderma	0.000414	0.00184	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000414	0.00184	CcSEcCtD
Cefadroxil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000411	0.00182	CcSEcCtD
Cefadroxil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000411	0.00182	CcSEcCtD
Cefadroxil—Diarrhoea—Azathioprine—systemic scleroderma	0.000404	0.00179	CcSEcCtD
Cefadroxil—Haemoglobin—Prednisone—systemic scleroderma	0.000403	0.00179	CcSEcCtD
Cefadroxil—Nausea—Captopril—systemic scleroderma	0.000402	0.00178	CcSEcCtD
Cefadroxil—Haemorrhage—Prednisone—systemic scleroderma	0.000401	0.00178	CcSEcCtD
Cefadroxil—Asthenia—Leflunomide—systemic scleroderma	0.0004	0.00178	CcSEcCtD
Cefadroxil—Pancytopenia—Methotrexate—systemic scleroderma	0.000397	0.00176	CcSEcCtD
Cefadroxil—Pruritus—Leflunomide—systemic scleroderma	0.000395	0.00175	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000392	0.00174	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—systemic scleroderma	0.000391	0.00174	CcSEcCtD
Cefadroxil—Dizziness—Azathioprine—systemic scleroderma	0.000391	0.00173	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000383	0.0017	CcSEcCtD
Cefadroxil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000382	0.00169	CcSEcCtD
Cefadroxil—Diarrhoea—Leflunomide—systemic scleroderma	0.000382	0.00169	CcSEcCtD
Cefadroxil—Urticaria—Lisinopril—systemic scleroderma	0.000381	0.00169	CcSEcCtD
Cefadroxil—Body temperature increased—Lisinopril—systemic scleroderma	0.000379	0.00168	CcSEcCtD
Cefadroxil—Abdominal pain—Lisinopril—systemic scleroderma	0.000379	0.00168	CcSEcCtD
Cefadroxil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000376	0.00167	CcSEcCtD
Cefadroxil—Vomiting—Azathioprine—systemic scleroderma	0.000376	0.00167	CcSEcCtD
Cefadroxil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00166	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—systemic scleroderma	0.000373	0.00166	CcSEcCtD
Cefadroxil—Rash—Azathioprine—systemic scleroderma	0.000372	0.00165	CcSEcCtD
Cefadroxil—Dermatitis—Azathioprine—systemic scleroderma	0.000372	0.00165	CcSEcCtD
Cefadroxil—Headache—Azathioprine—systemic scleroderma	0.00037	0.00164	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00037	0.00164	CcSEcCtD
Cefadroxil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00164	CcSEcCtD
Cefadroxil—Dizziness—Leflunomide—systemic scleroderma	0.000369	0.00164	CcSEcCtD
Cefadroxil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000364	0.00162	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00161	CcSEcCtD
Cefadroxil—Vomiting—Leflunomide—systemic scleroderma	0.000355	0.00157	CcSEcCtD
Cefadroxil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000353	0.00157	CcSEcCtD
Cefadroxil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Cefadroxil—Rash—Leflunomide—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Cefadroxil—Dermatitis—Leflunomide—systemic scleroderma	0.000351	0.00156	CcSEcCtD
Cefadroxil—Nausea—Azathioprine—systemic scleroderma	0.000351	0.00156	CcSEcCtD
Cefadroxil—Headache—Leflunomide—systemic scleroderma	0.000349	0.00155	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—systemic scleroderma	0.000348	0.00154	CcSEcCtD
Cefadroxil—Asthenia—Lisinopril—systemic scleroderma	0.000344	0.00153	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00152	CcSEcCtD
Cefadroxil—Pruritus—Lisinopril—systemic scleroderma	0.000339	0.0015	CcSEcCtD
Cefadroxil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000338	0.0015	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—systemic scleroderma	0.000337	0.00149	CcSEcCtD
Cefadroxil—Rash—Mycophenolic acid—systemic scleroderma	0.000336	0.00149	CcSEcCtD
Cefadroxil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000335	0.00149	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—systemic scleroderma	0.000335	0.00149	CcSEcCtD
Cefadroxil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00148	CcSEcCtD
Cefadroxil—Headache—Mycophenolic acid—systemic scleroderma	0.000333	0.00148	CcSEcCtD
Cefadroxil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000332	0.00147	CcSEcCtD
Cefadroxil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000332	0.00147	CcSEcCtD
Cefadroxil—Nausea—Leflunomide—systemic scleroderma	0.000331	0.00147	CcSEcCtD
Cefadroxil—Diarrhoea—Lisinopril—systemic scleroderma	0.000328	0.00146	CcSEcCtD
Cefadroxil—Angioedema—Prednisone—systemic scleroderma	0.000319	0.00141	CcSEcCtD
Cefadroxil—Dizziness—Lisinopril—systemic scleroderma	0.000317	0.00141	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—systemic scleroderma	0.000317	0.00141	CcSEcCtD
Cefadroxil—Nausea—Mycophenolic acid—systemic scleroderma	0.000316	0.0014	CcSEcCtD
Cefadroxil—Vertigo—Prednisone—systemic scleroderma	0.000313	0.00139	CcSEcCtD
Cefadroxil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00137	CcSEcCtD
Cefadroxil—Vomiting—Lisinopril—systemic scleroderma	0.000305	0.00135	CcSEcCtD
Cefadroxil—Rash—Lisinopril—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Cefadroxil—Convulsion—Prednisone—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Cefadroxil—Dermatitis—Lisinopril—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Cefadroxil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00134	CcSEcCtD
Cefadroxil—Headache—Lisinopril—systemic scleroderma	0.0003	0.00133	CcSEcCtD
Cefadroxil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00132	CcSEcCtD
Cefadroxil—Arthralgia—Prednisone—systemic scleroderma	0.000297	0.00132	CcSEcCtD
Cefadroxil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00128	CcSEcCtD
Cefadroxil—Nausea—Lisinopril—systemic scleroderma	0.000285	0.00126	CcSEcCtD
Cefadroxil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000285	0.00126	CcSEcCtD
Cefadroxil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Cefadroxil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00118	CcSEcCtD
Cefadroxil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00118	CcSEcCtD
Cefadroxil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Cefadroxil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00117	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—systemic scleroderma	0.000262	0.00116	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—systemic scleroderma	0.000253	0.00112	CcSEcCtD
Cefadroxil—Dyspepsia—Prednisone—systemic scleroderma	0.000251	0.00111	CcSEcCtD
Cefadroxil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00111	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—systemic scleroderma	0.000248	0.0011	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000238	0.00106	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Cefadroxil—Urticaria—Prednisone—systemic scleroderma	0.000226	0.001	CcSEcCtD
Cefadroxil—Abdominal pain—Prednisone—systemic scleroderma	0.000225	0.000999	CcSEcCtD
Cefadroxil—Body temperature increased—Prednisone—systemic scleroderma	0.000225	0.000999	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000217	0.000962	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—systemic scleroderma	0.000211	0.000939	CcSEcCtD
Cefadroxil—Hypersensitivity—Prednisone—systemic scleroderma	0.00021	0.000931	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—systemic scleroderma	0.000209	0.000929	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000205	0.000912	CcSEcCtD
Cefadroxil—Asthenia—Prednisone—systemic scleroderma	0.000204	0.000906	CcSEcCtD
Cefadroxil—Pruritus—Prednisone—systemic scleroderma	0.000201	0.000894	CcSEcCtD
Cefadroxil—Diarrhoea—Prednisone—systemic scleroderma	0.000195	0.000864	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000195	0.000863	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—systemic scleroderma	0.000189	0.000839	CcSEcCtD
Cefadroxil—Dizziness—Prednisone—systemic scleroderma	0.000188	0.000835	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—systemic scleroderma	0.000188	0.000835	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—systemic scleroderma	0.000188	0.000835	CcSEcCtD
Cefadroxil—Vomiting—Prednisone—systemic scleroderma	0.000181	0.000803	CcSEcCtD
Cefadroxil—Rash—Prednisone—systemic scleroderma	0.000179	0.000797	CcSEcCtD
Cefadroxil—Dermatitis—Prednisone—systemic scleroderma	0.000179	0.000796	CcSEcCtD
Cefadroxil—Headache—Prednisone—systemic scleroderma	0.000178	0.000791	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—systemic scleroderma	0.000175	0.000778	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—systemic scleroderma	0.000171	0.000758	CcSEcCtD
Cefadroxil—Nausea—Prednisone—systemic scleroderma	0.000169	0.00075	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—systemic scleroderma	0.000168	0.000747	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—systemic scleroderma	0.000163	0.000722	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—systemic scleroderma	0.000157	0.000698	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—systemic scleroderma	0.000151	0.000671	CcSEcCtD
Cefadroxil—Rash—Methotrexate—systemic scleroderma	0.00015	0.000666	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—systemic scleroderma	0.00015	0.000665	CcSEcCtD
Cefadroxil—Headache—Methotrexate—systemic scleroderma	0.000149	0.000661	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—systemic scleroderma	0.000141	0.000627	CcSEcCtD
